Summary by Moomoo AI
Rong Chang Bio-released its first quarter report for 2024, showing that operating income reached RMB330,434,802.62, up 96.41% year-on-year. However, the company's net profit attributable to shareholders of listed companies was RMB348,921,696.49 and basic earnings per share were $0.65. R&D INVESTMENT TOTALLED $331,178,800.01, ACCOUNTING FOR 100.23% OF OPERATING INCOME, A DECREASE OF 48.20 PERCENTAGE POINTS COMPARED TO THE SAME PERIOD LAST YEAR. At the end of the reporting period, the Company's total assets were $5,478,656,892.82, a decrease of 0.90% year-on-year, and the shareholders' equity attributable to the listed company's shareholders was $3,078,552,195.74, a decrease of 10.44%. The financial statements for the quarter have not been audited and the financial data are based on Chinese accounting standards and not international financial reporting standards. The Board of Directors reminds shareholders and potential investors to exercise caution in the absence of an independent auditor's review. The report was issued by Chairman and Executive Director Mr. Wang Weidong on 26 April 2024.